News
Featured Image
Charlie Gard

LONDON, July 18, 2017 (LifeSiteNews) – American Dr. Michio Hirano and a doctor from a Vatican hospital examined baby Charlie Gard yesterday, and today have a critical meeting with his hospital. 

Hirano has previously testified that he thinks Charlie has a 10 to 56 percent chance of improving with new cutting-edge treatment. Hirano is one of the world's leading experts on mitochondrial disease. Bambino Gesù Hospital in Rome has previously offered to admit and treat Charlie.

Charlie has a rare mitochondrial disease. His parents have raised more than $1.5 million to transfer him to the U.S. for experimental treatment, but English and European courts have ruled that his hospital can block his parents' wishes and pull the 11-month-old's life support.

The Daily Mail reported that Hirano and the Vatican doctor examined Charlie for five hours. He received a brain scan for which at least one of his parents was present. Charlie's government-appointed lawyer, who is supposed to argue for his interests but is a euthanasia activist, previously tried to prevent Charlie's parents from being allowed at this meeting. She was unsuccessful. 

The Daily Mail called Hirano's meeting with Great Ormond Street Hospital today a “make-or-break” moment in Charlie's case. 

Mr. Justice Francis, the judge who is re-examining Charlie's case, will make a determination about Charlie's fate on or around July 25. Hirano's findings will likely have a strong influence his decision. 

Comments

Commenting Guidelines
LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.

0 Comments

    Loading...